ESMO Highlights of the Year 2022 – Lung cancer
We selected two studies in the field of lung cancer presented at this year’s ESMO congress as highlights of the year. Both studies deal with targeted therapies in metastatic non-small cell-lung cancer (NSCLC).
Anmelden und kostenlos alle Tools nutzen
Entdecken Sie das gesamte Angebot (z.B. Scores, Guidelines, Veranstaltungen, Drugshortages, Cochrane Library, Compendium)